Recently, Li et al. [94] reported significant improvement in visceral hyperalgesia among patients with irritable bowel syndrome (IBS) following treatment with LP17, providing valuable evidence implicating TREM1 in pain regulation. This evidence concerns the gene TREM1 and irritable bowel syndrome.